(Q42854436)

English

Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up

scientific article published on October 19, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

author name string

Stephen Kilfeather

2

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

David Cheung

3

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Henri Kafé

4

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Noël Schlösser

6

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Hans-Jochen Weber

8

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Renate Engelstätter

9

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Brian J. O'Connor

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20958119

5 August 2024

Mark D. Blagden

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20958119

5 August 2024

Jon G. Ayres

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20958119

5 August 2024

language of work or name

0 references

publication date

19 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

full work available at URL

http://www.informapharmascience.com/doi/abs/10.1517/14656566.2010.526603

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20958119

5 August 2024

http://www.tandfonline.com/doi/pdf/10.1517/14656566.2010.526603

1 reference

10.1517/14656566.2010.526603

https://api.crossref.org/works/10.1517/14656566.2010.526603

5 August 2024

Expert Opinion on Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

2791-2803

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Inhaled glucocorticoids for asthma

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Population pharmacokinetics and pharmacodynamics of ciclesonide.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Clinical pharmacokinetic and pharmacodynamic profile of inhaled ciclesonide

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Once-daily ciclesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Standardization of Spirometry, 1994 Update. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Significant variability in response to inhaled corticosteroids for persistent asthma

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Systemic effect comparisons of six inhaled corticosteroid preparations

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Circadian rhythm of serum cortisol after repeated inhalation of the new topical steroid ciclesonide

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Randomized comparison of the efficacy and safety of ciclesonide and budesonide in adolescents with severe asthma

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.526603

21 January 2018

Side effects of inhaled corticosteroids

4

1 reference

10.1517/14656566.2010.526603

https://api.crossref.org/works/10.1517/14656566.2010.526603

5 August 2024

Adverse effects of inhaled corticosteroids

6

1 reference

10.1517/14656566.2010.526603

https://api.crossref.org/works/10.1517/14656566.2010.526603

5 August 2024

Guidelines for the evaluation of impairment/disability in patients with asthma. American Thoracic Society. Medical Section of the American Lung Association

18

1 reference

10.1517/14656566.2010.526603

https://api.crossref.org/works/10.1517/14656566.2010.526603

5 August 2024

Measurements of morning and evening airflow grossly underestimate the circadian variability of FEV1 and peak expiratory flow rate in asthma

19

1 reference

10.1517/14656566.2010.526603

https://api.crossref.org/works/10.1517/14656566.2010.526603

5 August 2024

Ciclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthma

21

1 reference

10.1517/14656566.2010.526603

https://api.crossref.org/works/10.1517/14656566.2010.526603

5 August 2024

Identifiers

10.1517/14656566.2010.526603

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42854436&oldid=2221562817"